ARVO2020 cancelled because of Coronavirus (COVID-19)
ARVO has decided to cancel the Annual Meeting to have taken place May 1 – 7 in Baltimore, Md, USA
ARVO has decided to cancel the Annual Meeting to have taken place May 1 – 7 in Baltimore, Md, USA
Basel Series of Special Interest Focus Groups (SIFG) - „New Technologies for Outcome Measures in Uveal Melanoma” In Collaboration with the European Ocular Oncology Group and the International Society of Ocular Oncology
A drive-through intraocular pressure (IOP) screening clinic allows for continued management during the COVID-19 pandemic, according to a research letter published in JAMA Ophthalmology.
High-tech tools are increasingly being consolidated into specialized centres. Running these technological wonderlands takes a unique blend of skills.
A new global study has found no significant reduction in the number of people with treatable sight loss since 2010. Published in The Lancet Global Health, it examined population-based surveys of eye disease worldwide from 1980 and found public health services across the world are failing to meet targets to reduce avoidable sight loss.
2020 has been a year like no other. The COVID-19 pandemic pushed science to the forefront and dominated lives. But the year also produced fresh images unrelated to the virus.
RetinAI Medical AG announces a multi-year collaboration with Novartis Pharma AG under which RetinAI’s IT solutions and artificial intelligence tools shall be employed to support multiple projects in ophthalmology and digital health. Both companies have previously worked successfully on pilot projects in this disease area.
In light of the ongoing COVID-19 pandemic, the Glaucoma Research Foundation will host a virtual Glaucoma 360 annual meeting in 2021.
The Association for Research in Vision and Ophthalmology announced the switch to a virtual format this week for its annual meeting, originally scheduled for May 2-6 in San Francisco.
Ram Liebenthal, U.S. general manager for Heidelberg Engineering, discusses how the company continues to invest in the Spectralis platform in terms of hardware and software improvements.
The American Academy of Ophthalmology today announced the appointment of Emily Chew, MD, as editor in chief of Ophthalmology Science, the fourth and newest addition to the Academy’s Ophthalmology® family of journals. Dr. Chew is a highly respected medical retina specialist and editor, with extensive experience in the design and implementation of clinical trials.
The number of Americans who are nearsighted has nearly doubled over the last 50 years to about 41.6 percent. This upward trend is evident in nearly every corner of the world, but nowhere near as dramatic as in East and Southeast Asia, where 80 to 90 percent of children and young adults are myopic.
Kristen Brotherson, vice president, US surgical marketing for Alcon, discusses some of the recent advances in cataract surgery-related technologies, including a new advanced lens for patients with presbyopia (AcrySof IQ Vivity IOL).
Last-minute budget increase still leaves the upcoming Horizon Europe programme billions short of campaigners’ hopes.
The election of Biden and Kamala Harris is a win for facts, research and empathy. Each of these must be deployed to fight the pandemic, combat misinformation, mitigate climate change and rebuild the United States’ global relationships.